Learn why SignPath Pharma chose KamTek as their trusted logistics partner for Phase 1 Glioblastoma clinical trial drug shipments requiring -20°C cold chain precision.

See how KamTek developed and validated a scalable Defibrination protocol to meet ATCC’s critical and urgent request—preserving COVID-19 antibody integrity and ensuring secure -80°C sample delivery.

Ready to Partner with KamTek ?